Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Cryptococcosis Drugs Market by Type (Amphotericin B, Flucytosine, Fluconazole, Others), By Application (Hospital Pharmacy, Retail Pharmacies, Other) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Cryptococcosis Drugs Market by Type (Amphotericin B, Flucytosine, Fluconazole, Others), By Application (Hospital Pharmacy, Retail Pharmacies, Other) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 237117 4200 Pharma & Healthcare 377 166 Pages 4.7 (46)
                                          

Market Overview:


The global cryptococcosis drugs market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cryptococcosis, rising demand for better treatment options, and growing awareness about cryptococcosis. Based on type, the global cryptococcosis drugs market is segmented into amphotericin B, flucytosine, fluconazole, and others. Amphotericin B held the largest share of the global cryptococcus drugs market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to its high efficacy against Cryptococcus neoformans infections and growing demand for better treatment options for patients with cryptococcal meningitis.


Global Cryptococcosis Drugs Industry Outlook


Product Definition:


Cryptococcosis is a fungal infection caused by Cryptococcus neoformans or Cryptococcus gattii. It can affect the lungs (pneumonia), brain (meningitis), or other organs. Treatment with antifungal drugs is usually effective.


Amphotericin B:


Amphotericin B (AB) is an antibiotic used for the treatment of fungal infections. It works by killing the fungi that cause infection in the body. The drug has a wide spectrum of activity against various pathogenic fungi, including Candida albicans, Aspergillus flavus and Aspergillus niger.


Flucytosine:


It is an antibiotic medication used to treat bacterial meningitis and brain infections. Flucytosine is also used in the treatment of acute infectious diseases, chronic inflammatory demyelinating polyneuropathy (CIDP), and acute viral meningitis. It works by blocking sodium channels in the cell membranes of infected cells.


Application Insights:


Based on application, the global market is segmented into hospital pharmacy, retail pharmacies and others. Hospital pharmacy held the largest share in 2017 owing to increasing prevalence of cryptococcosis-related diseases in hospitals across the world. In addition, growing number of hospital-based dispensing facilities for medication is also expected to contribute towards segment growth over the forecast period.


Retail pharmacies are anticipated to witness significant growth over the forecast period due to rising awareness about availability of generic drugs and government initiatives such as Make in India that encourage manufacturing at affordable costs within reachable markets for consumers. This factor has led many manufacturers toward production at lower costs within regional markets thus making them more accessible through local shops thereby boosting demand globally during recent years.


The other application segment includes institutions (hospitals & clinics), home healthcare settings and others (such as research laboratories).


Regional Analysis:


North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing healthcare expenditure and rising prevalence of fungal infections. In addition, growing number of product launches and FDA approvals are also contributing towards growth in this region. For instance, in May 2018, Vifor Pharma announced that it received approval for ZoptEC drug formulation from Health Canada for treatment of cryptococcal disease (Coccidioidal Infection).


Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rise in disposable income coupled with increase awareness about various treatment options available for fungal diseases such as coccidioidal infections. Moreover, availability of generic drugs at low prices will also boost regional market growth over the next eight years.


Growth Factors:


  • Increasing incidence of Cryptococcosis
  • Rising demand for Cryptococcosis Drugs in the developing countries
  • Technological advancements in the field of Cryptococcosis Drugs research and development
  • Growing awareness about Cryptococcosis and its treatment options
  • Availability of government funding for research on Cryptococcosis Drugs

Scope Of The Report

Report Attributes

Report Details

Report Title

Cryptococcosis Drugs Market Research Report

By Type

Amphotericin B, Flucytosine, Fluconazole, Others

By Application

Hospital Pharmacy, Retail Pharmacies, Other

By Companies

Abbott, Pfizer, Bristol-Mayers Squibb, Sigmapharm Laboratories, Novartis, Glenmark Pharmaceuticals

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

166

Number of Tables & Figures

117

Customization Available

Yes, the report can be customized as per your need.


Global Cryptococcosis Drugs Market Report Segments:

The global Cryptococcosis Drugs market is segmented on the basis of:

Types

Amphotericin B, Flucytosine, Fluconazole, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital Pharmacy, Retail Pharmacies, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Abbott
  2. Pfizer
  3. Bristol-Mayers Squibb
  4. Sigmapharm Laboratories
  5. Novartis
  6. Glenmark Pharmaceuticals

Global Cryptococcosis Drugs Market Overview


Highlights of The Cryptococcosis Drugs Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Amphotericin B
    2. Flucytosine
    3. Fluconazole
    4. Others
  1. By Application:

    1. Hospital Pharmacy
    2. Retail Pharmacies
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Cryptococcosis Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Cryptococcosis Drugs Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Cryptococcosis drugs are medications used to treat cryptococcosis, a fungal infection of the lungs. These drugs help to clear the fungus from the lungs and may also help to prevent future infections. Cryptococcosis drugs include amphotericin B (AmB), itraconazole (Sporanox), voriconazole (Vfend), and posaconazole (Nexavar).

Some of the major companies in the cryptococcosis drugs market are Abbott, Pfizer, Bristol-Mayers Squibb, Sigmapharm Laboratories, Novartis, Glenmark Pharmaceuticals.

The cryptococcosis drugs market is expected to register a CAGR of 7.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cryptococcosis Drugs Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Cryptococcosis Drugs Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Cryptococcosis Drugs Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Cryptococcosis Drugs Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Cryptococcosis Drugs Market Size & Forecast, 2018-2028       4.5.1 Cryptococcosis Drugs Market Size and Y-o-Y Growth       4.5.2 Cryptococcosis Drugs Market Absolute $ Opportunity

Chapter 5 Global Cryptococcosis Drugs Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Cryptococcosis Drugs Market Size Forecast by Type
      5.2.1 Amphotericin B
      5.2.2 Flucytosine
      5.2.3 Fluconazole
      5.2.4 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Cryptococcosis Drugs Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Cryptococcosis Drugs Market Size Forecast by Applications
      6.2.1 Hospital Pharmacy
      6.2.2 Retail Pharmacies
      6.2.3 Other
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Cryptococcosis Drugs Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Cryptococcosis Drugs Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Cryptococcosis Drugs Analysis and Forecast
   9.1 Introduction
   9.2 North America Cryptococcosis Drugs Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Cryptococcosis Drugs Market Size Forecast by Type
      9.6.1 Amphotericin B
      9.6.2 Flucytosine
      9.6.3 Fluconazole
      9.6.4 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Cryptococcosis Drugs Market Size Forecast by Applications
      9.10.1 Hospital Pharmacy
      9.10.2 Retail Pharmacies
      9.10.3 Other
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Cryptococcosis Drugs Analysis and Forecast
   10.1 Introduction
   10.2 Europe Cryptococcosis Drugs Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Cryptococcosis Drugs Market Size Forecast by Type
      10.6.1 Amphotericin B
      10.6.2 Flucytosine
      10.6.3 Fluconazole
      10.6.4 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Cryptococcosis Drugs Market Size Forecast by Applications
      10.10.1 Hospital Pharmacy
      10.10.2 Retail Pharmacies
      10.10.3 Other
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Cryptococcosis Drugs Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Cryptococcosis Drugs Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Cryptococcosis Drugs Market Size Forecast by Type
      11.6.1 Amphotericin B
      11.6.2 Flucytosine
      11.6.3 Fluconazole
      11.6.4 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Cryptococcosis Drugs Market Size Forecast by Applications
      11.10.1 Hospital Pharmacy
      11.10.2 Retail Pharmacies
      11.10.3 Other
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Cryptococcosis Drugs Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Cryptococcosis Drugs Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Cryptococcosis Drugs Market Size Forecast by Type
      12.6.1 Amphotericin B
      12.6.2 Flucytosine
      12.6.3 Fluconazole
      12.6.4 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Cryptococcosis Drugs Market Size Forecast by Applications
      12.10.1 Hospital Pharmacy
      12.10.2 Retail Pharmacies
      12.10.3 Other
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Cryptococcosis Drugs Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Cryptococcosis Drugs Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Cryptococcosis Drugs Market Size Forecast by Type
      13.6.1 Amphotericin B
      13.6.2 Flucytosine
      13.6.3 Fluconazole
      13.6.4 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Cryptococcosis Drugs Market Size Forecast by Applications
      13.10.1 Hospital Pharmacy
      13.10.2 Retail Pharmacies
      13.10.3 Other
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Cryptococcosis Drugs Market: Competitive Dashboard
   14.2 Global Cryptococcosis Drugs Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Abbott
      14.3.2 Pfizer
      14.3.3 Bristol-Mayers Squibb
      14.3.4 Sigmapharm Laboratories
      14.3.5 Novartis
      14.3.6 Glenmark Pharmaceuticals

Our Trusted Clients

Contact Us